Alan J. Hirschfield, Director at Cantel Medical Corp (NYSE:CMN) disclosed the disposal of 20,000 shares of common stock through two separate transactions on October 17, 2014. The first transaction involved 5,079 shares, sold for an average unit price of $37.006, and the second for a total of 14,921 shares at an average price of $36.974 each. Mr. Hirschfield counts now nine sales this year, the first two since August, and now owns (directly) a total of 421,741 shares.
Mr. Hirschfield’s pessimist outlook on the company is supported by the sale of shares by other high company officials. Eric W Nodiff, Senior VP and General Counsel , Steven C. Anaya, VP and Controller, and Andrew A. Krakauer, President and CEO at Cantel Medical Corp (NYSE:CMN) have sold 8,000, 9,108 and 37,267 shares, correspondingly, during last week.
Mark N. Diker’s Diker Management, the largest shareholding institution (amongst those we track), is also pessimistic about Cantel Medical Corp (NYSE:CMN). The fund last reported a 1% decline in its holdings, keeping 2.6 million shares, valued at an estimate $95 million.
Cantel Medical Corp (NYSE:CMN) is a provider of infection prevention and control products and services in the healthcare market.